NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 123 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $128,239 | 0.0% | 31,431 | 0.0% | 0.00% | – |
| Q1 2023 | $128,239 | -18.7% | 31,431 | 0.0% | 0.00% | – |
| Q4 2022 | $157,783 | -100.0% | 31,431 | +2.2% | 0.00% | – |
| Q3 2022 | $402,432,000 | -9.4% | 30,767 | -11.2% | 0.00% | – |
| Q2 2022 | $444,379,000 | +56.4% | 34,663 | +86.1% | 0.00% | – |
| Q1 2022 | $284,093,000 | -13.9% | 18,629 | 0.0% | 0.00% | – |
| Q4 2021 | $329,919,000 | -37.1% | 18,629 | -25.3% | 0.00% | – |
| Q3 2021 | $524,344,000 | +160.9% | 24,945 | +144.8% | 0.00% | – |
| Q2 2021 | $200,967,000 | – | 10,191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,766,666 | $59,928,000 | 49.90% |
| Greenspring Associates, LLC | 1,573,357 | $25,032,000 | 38.95% |
| Svennilson Peter | 18,017,932 | $286,665,000 | 23.39% |
| Aquilo Capital Management, LLC | 1,018,334 | $16,202,000 | 1.72% |
| Jasper Ridge Partners, L.P. | 308,750 | $4,912,000 | 0.28% |
| Samsara BioCapital, LLC | 36,451 | $580,000 | 0.16% |
| Rock Springs Capital Management LP | 360,454 | $5,735,000 | 0.15% |
| Point72 Asset Management, L.P. | 1,611,850 | $25,645,000 | 0.13% |
| Virtus ETF Advisers LLC | 14,880 | $237,000 | 0.12% |
| WELD CAPITAL MANAGEMENT LLC | 15,238 | $242,000 | 0.10% |